Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2008-9-19
pubmed:abstractText
Rejection of solid organ allografts is promoted by T cells. Recipient T cells can directly recognize intact allo-MHC molecules on donor cells and can also indirectly recognize processed donor-derived allo-peptides presented by recipient antigen-presenting cells in the context of self-MHC molecules. Although CD4(+) T cells primed through the indirect allorecognition pathway alone are sufficient to promote acute allograft rejection, it is unknown how they can mediate graft destruction without cognate recognition of donor cells. In this study, we analyzed the indirect effector mechanism of skin allograft rejection using a mouse model in which SCID recipients bearing MHC class II-deficient skin allografts were adoptively transferred with CD4(+) T cells. Histologically, entire graft necrosis was preceded by mononuclear cell infiltration in the graft epithelia with epithelial cell apoptosis, indicating cell-mediated cytotoxicity against donor cells as an effector mechanism. Beside CD4(+) T cells and macrophages, NK cells infiltrated in the rejecting grafts. Depletion of NK cells as well as blocking of the activating NK receptor NKG2D allowed prolonged survival of the grafts. Expression of NKG2D ligands was up-regulated in the rejecting grafts. These results suggest that NK cells activated through NKG2D contribute to the skin allograft rejection promoted by indirectly primed CD4(+) T cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1460-2377
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1343-9
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:18697765-Animals, pubmed-meshheading:18697765-Antibodies, Blocking, pubmed-meshheading:18697765-Antigen Presentation, pubmed-meshheading:18697765-CD4-Positive T-Lymphocytes, pubmed-meshheading:18697765-Cross-Priming, pubmed-meshheading:18697765-Female, pubmed-meshheading:18697765-Genes, MHC Class II, pubmed-meshheading:18697765-Graft Rejection, pubmed-meshheading:18697765-Killer Cells, Natural, pubmed-meshheading:18697765-Lymphocyte Activation, pubmed-meshheading:18697765-Lymphocyte Depletion, pubmed-meshheading:18697765-Mice, pubmed-meshheading:18697765-Mice, Inbred BALB C, pubmed-meshheading:18697765-Mice, Inbred C57BL, pubmed-meshheading:18697765-Mice, SCID, pubmed-meshheading:18697765-NK Cell Lectin-Like Receptor Subfamily K, pubmed-meshheading:18697765-Receptors, Immunologic, pubmed-meshheading:18697765-Receptors, Natural Killer Cell, pubmed-meshheading:18697765-Skin Transplantation, pubmed-meshheading:18697765-Transplantation, Homologous, pubmed-meshheading:18697765-Transplantation Immunology
pubmed:year
2008
pubmed:articleTitle
NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
pubmed:affiliation
Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't